Sanaa M. Kamal
Elsevier Science
e druk, 2017
9780128032336
Hepatitis C in Developing Countries
Current and Future Challenges
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
2017
ISBN13: 9780128032336
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.
Specificaties
Inhoudsopgave
<p>1. Global Burden of Hepatitis C <br>Section 1.1 The Public Health and Health Care Burden of Hepatitis C Infection <br>Section 1.2 The Economic Burden of Hepatitis C Infection <br>Section 1.3 The Social Burden of Hepatitis C Infection</p> <p>2. The Epidemic of Hepatitis C in Developing Countries<br>Section 2.1 HCV Statistics in Developing Countries<br>Section 2.2 The Growing Challenge of Hepatitis C in Developing Countries<br>Subsection 2.2.a Epidemiology of Hepatitis C in Developing Countries<br>Subsection 2.2.b Modes of Transmission of Hepatitis C in Developing Countries<br>Subsection 2.2 c Socio-political Aspects of Hepatitis C in Developing Countries<br>Subsection 2.2.d. Hepatitis C Genotypes in Developing Countries<br>Subsection 2.2 e. Clinical Patterns and Complications of Hepatitis C Infection in Developing Countries<br>Subsection 2.2.e Access to Hepatitis C Treatment in Developing Countries <br>Subsection 2.2.f. Impact of Coinfections on Hepatitis C in Developing Countries<br>Section 2.3 Macro and Micro-economics of Hepatitis C in Developing Countries</p> <p>3. The Magnitude of Hepatitis C Problem in Specific Regions <br>Section 3.1 Hepatitis C in Egypt <br>Section 3.2 Hepatitis C in Africa <br>Section 3.3 Hepatitis C in the Middle East <br>Section 3.1 Hepatitis C in Indian Subcontinent <br>Section 3.2 Hepatitis C in Latin America <br>Section 3.3 Hepatitis C in Southeast Asia</p> <p>4. Challenges of Hepatitis C in Developing Countries <br>Section 4.1 Direct Acting Antiviral Agents in Developing Countries <br>Section 4.2 Challenges of Producing Drugs and Potential Vaccines for Hepatitis C Specifically for Developing Countries<br>Section 4.3 Ethics of Hepatitis C Clinical Trials and Research in Developing Countries <br>Section 4.4 Applications of Genetics in Developing Countries <br>Section 4.5 Hepatitis C Surveillance and Prevention in Developing Countries</p>